EndocrineCo-targeting of metabolism using dietary and pharmacologic approaches reduces breast cancer metastatic burden
Metastatic breast cancer reduces patients’ survival and quality of life. Fulvestrant (Fulv), an estrogen receptor (ER) antagonist, is used for ER-positive metastatic breast cancer, but...